Bilateral Anterior Segment Hyphema and Ocular Hypotony Following Treatment with Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto).
증례보고
1/5 보강
[PURPOSE] We describe a case of severe bilateral anterior segment neovascularization leading to hyphema in a patient treated with Lutetium (177Lu) vipivotide tetraxetan for metastatic castration-resis
APA
Henry RK, Habiel M, et al. (2025). Bilateral Anterior Segment Hyphema and Ocular Hypotony Following Treatment with Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto).. Ocular immunology and inflammation, 33(8), 1799-1802. https://doi.org/10.1080/09273948.2025.2504582
MLA
Henry RK, et al.. "Bilateral Anterior Segment Hyphema and Ocular Hypotony Following Treatment with Lutetium (177Lu) Vipivotide Tetraxetan (Pluvicto).." Ocular immunology and inflammation, vol. 33, no. 8, 2025, pp. 1799-1802.
PMID
40388322 ↗
Abstract 한글 요약
[PURPOSE] We describe a case of severe bilateral anterior segment neovascularization leading to hyphema in a patient treated with Lutetium (177Lu) vipivotide tetraxetan for metastatic castration-resistant prostate cancer (mCRPC).
[METHODS] Case report with multimodal imaging.
[RESULTS] A 77-year-old patient was referred for evaluation of a two-day history of blurry vision. At presentation, the exam was significant for bilateral hyphema, elevated intraocular pressure, and significant microcystic edema. Gonioscopy revealed neovascularization of the anterior segment. Multimodal imaging revealed intraretinal hemorrhages without neovascular retinopathy, metastases, or carotid occlusive disease. The patient was treated medically, but developed significant hypotony necessitating postponement of therapy.
[CONCLUSION] This case demonstrates a potential ocular adverse reaction to Lutetium (177Lu) vipivotide tetraxetan therapy.
[METHODS] Case report with multimodal imaging.
[RESULTS] A 77-year-old patient was referred for evaluation of a two-day history of blurry vision. At presentation, the exam was significant for bilateral hyphema, elevated intraocular pressure, and significant microcystic edema. Gonioscopy revealed neovascularization of the anterior segment. Multimodal imaging revealed intraretinal hemorrhages without neovascular retinopathy, metastases, or carotid occlusive disease. The patient was treated medically, but developed significant hypotony necessitating postponement of therapy.
[CONCLUSION] This case demonstrates a potential ocular adverse reaction to Lutetium (177Lu) vipivotide tetraxetan therapy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
- Humans
- Male
- Aged
- Ocular Hypotension
- Hyphema
- Lutetium
- Anterior Eye Segment
- Somatostatin
- Intraocular Pressure
- Prostatic Neoplasms
- Castration-Resistant
- Radioisotopes
- Radiopharmaceuticals
- Gonioscopy
- Tomography
- Optical Coherence
- 177 Lu-PSMA-617
- anterior segment ischemia
- hyphema
- lutetium
- lutetium (177Lu) Vipivotide Tetraxetan Pluvicto
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.